{"mainPropery":{"diseaseId":10185,"diseaseName":"Chester porphyria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10185/chester-porphyria","synonyms":["Porphyria, Chester type","PORC"],"synonyms-with-source":[{"name":"Porphyria, Chester type"},{"name":"PORC"}],"identifiers":[{"identifierType":"OMIM","identifierId":"176010"},{"identifierType":"UMLS","identifierId":"C0268322"}]},"diseaseCategories":[],"organizations":[{"resourceID":69,"resourceName":" American Porphyria Foundation","abbreviation":"","address1":"4915 St. Elmo Avenue","address2":"Suite 105","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814","country":"United States","phone":"+1-301-347-7166","tty":"","tollFree":"1-866-273-3635","fax":"+1-301-312-8719","email":"porphyrus@porphyriafoundation.com","url":"https://porphyriafoundation.org/","freeText":""},{"resourceID":942,"resourceName":"American Association for the Study of Liver Diseases","abbreviation":"","address1":"1001 North Fairfax, 4th floor","address2":"","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"703–299–9766","tty":"","tollFree":"","fax":"703–299–9622","email":"aasld@aasld.org","url":"http://www.aasld.org/","freeText":""},{"resourceID":943,"resourceName":"American Liver Foundation","abbreviation":"","address1":"39 Broadway, Suite 2700","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10006","country":"United States","phone":"+1-212-668-1000","tty":"","tollFree":"+1-800-465-4837 (Helpline)","fax":"","email":"https://liverfoundation.org/for-patients/contact-us/","url":"https://liverfoundation.org/","freeText":""},{"resourceID":3192,"resourceName":"European Porphyria Network","abbreviation":"EPNET","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"https://porphyria.eu/en/contact","url":"https://porphyria.eu/en","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/176010' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=176010' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Chester porphyria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=porphyria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Chester porphyria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/porphyria' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1366,"resourceId":2017,"resourceName":"Porphyria Disease Management","descriptionText":"The American Porphyria Foundation offers a <a href='https://www.porphyriafoundation.org/for-patients/about-porphyria/' target='_blank'>document</a> that includes information about porphyria, types, testing, and treatment with <a href='https://porphyriafoundation.org/patients/about-porphyria/treatment-options' target='_blank'>Panhematin</a><sup>&#174;</sup>.  Click the \"document\" link above to view these guidelines.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/topic1881.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/19016728' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:176000' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/porphyrias' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":1153,"questionText":"What is Chester porphyria?","answerText":"<strong>Chester porphyria</strong> is a unique type of porphyria with the signs and symptoms of <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP\" target=\"_blank\">acute intermittent porphyria (AIP)</a> and the biochemical defects of both AIP and <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/VP\" target=\"_blank\">variegate porphyria (VP)</a>.&nbsp; Chester porphyria does not conform to any of the recognized types of <a href=\"http://www.emedicine.com/ped/topic1870.htm\" target=\"_blank\">acute porphyria</a>. The symptoms associated with Chester porphyria are similar to those observed in other acute porphyrias. Treatment is symptomatic.[692]","dateModified":"2015-11-12T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":17992,"abbreviatedInquiry":"What can you tell me about acute intermittent porphyria and Chester porphyria?","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1153,"questionText":"What is Chester porphyria?","answerText":"<strong>Chester porphyria</strong> is a unique type of porphyria with the signs and symptoms of <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP\" target=\"_blank\">acute intermittent porphyria (AIP)</a> and the biochemical defects of both AIP and <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/VP\" target=\"_blank\">variegate porphyria (VP)</a>.&nbsp; Chester porphyria does not conform to any of the recognized types of <a href=\"http://www.emedicine.com/ped/topic1870.htm\" target=\"_blank\">acute porphyria</a>. The symptoms associated with Chester porphyria are similar to those observed in other acute porphyrias. Treatment is symptomatic.[692]","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1154,"questionText":"What are the symptoms of Chester porphyria?","answerText":"Chester porphyria causes the same symptoms&nbsp;common to all <a href=\"http://emedicine.medscape.com/article/957604-clinical#showall\" target=\"_blank\">acute porphyrias</a>. Unlike in variegate porphyrias,&nbsp;skin sensitivity to light is not a feature of Chester porphyria.[692]&nbsp; To view a list of symptoms seen in Chester porphyria, <a href=\"http://emedicine.medscape.com/article/205314-clinical#showall\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1155,"questionText":"What causes Chester porphyria?","answerText":"Genetic studies have&nbsp;linked Chester porphyria&nbsp;to a <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">gene</a>&nbsp;located on the long (q) arm of <a href=\"http://ghr.nlm.nih.gov/chromosome=11#ideogram\" target=\"_blank\">chromosome 11</a>.[692] <br />\r\n<br />\r\nSome of the&nbsp;activating factors include [692]: <br />\r\n<br />\r\n&bull; Drugs (e.g., barbiturates,&nbsp;aluminum hydroxide,&nbsp;tricyclic antidepressants, alcohol)&nbsp;<br />\r\n&bull; Smoking <br />\r\n&bull; Surgery <br />\r\n&bull; Metabolic abnormalities such as low levels of sodium (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000394.htm\" target=\"_blank\">hyponatremia</a>)","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1156,"questionText":"How is Chester porphyria inherited?","answerText":"Although the gene that causes Chester porphyria has not been identified, the condition is believed to be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant </a>manner.[692]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1157,"questionText":"How might Chester porphyria be treated?","answerText":"The goal of management is to avoid&nbsp;activating factors. Treatment is symptomatic.[692]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Chester_porphyria"}